Chronic Lung Disease: Clinical Trials

3 trials for Chronic Lung Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Suspended 1, Unknown 1
Phase 31Unknown 1

Follow Chronic Lung Disease: new trials by email Literature Review of Chronic Lung Disease trials Research Report on Chronic Lung Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study
surfactant airway device - RDS of Prematurity, Surfactant Protein B Deficiency
Phase 2SuspendedONY552025-02-072023-11-01
Antibiotic "Dysbiosis" in Preterm Infants
Antibiotic, Gastric fluid, Breast milk - Enterocolitis, Necrotizing, Bacteremia
Phase 2CompletedUniversity of Florida982017-01-162024-06-05
Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
Spironolactone, Placebo - Chronic Lung Disease, Bronchopulmonary Dysplasia
Phase 2 / Phase 3UnknownWest Virginia University Healthcare402012-10-012016-11-30

Narrower conditions

Bronchopulmonary Dysplasia (2)  ·  Bacteremia (1)  ·  Enterocolitis, Necrotizing (1)  ·  Leukomalacia, Periventricular (1)  ·  Respiratory Distress Syndrome In Premature Infants (1)  ·  Surfactant Metabolism Dysfunction, Pulmonary, 1 (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Infant, Newborn, Diseases (2)  ·  Infant, Premature, Diseases (2)  ·  Lung Diseases (2)  ·  Lung Injury (2)  ·  Respiratory Tract Diseases (2)  ·  Ventilator-Induced Lung Injury (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Digestive System Diseases (1)  ·  Encephalomalacia (1)

Interventions

Ampicillin (1)  ·  Anti-Bacterial Agents (1)  ·  Cefotaxime (1)  ·  Gentamicins (1)  ·  Milk, Human (1)  ·  Spironolactone (1)

Sponsors

ONY (1)  ·  University of Florida (1)  ·  West Virginia University Healthcare (1)

Countries

United States (3)

Top investigators

Courtney B Sweet, PharmD (1)  ·  Josef Neu, MD (1)  ·  Kari Roberts, MD (1)

Results publications

PMID 33479274, PMID 37308133, PMID 39373498

NIH funding

R21HD088005 (1)